
- Telehealth Visits
- Insurance plan information

Mindy Goldman, MD
Obstetrics and Gynecology • Gynecology- Telehealth Visits
- Insurance plan information



Mindy Goldman, MD
Obstetrics and Gynecology • Gynecology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Mindy Goldman is a gynecologist with particular expertise in providing specialized gynecologic care for women with breast cancer and women at risk for cancer.
Goldman earned her medical degree from the Larner College of Medicine at the University of Vermont. She completed a residency in obstetrics and gynecology at UCSF.
Education & training
Board certification
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Residency
- Obstetrics & Gynecology, UCSF Medical Center House Staff
Internship
- Obstetrics & Gynecology, UCSF Medical Center House Staff
Degree
- MD, University of Vermont
My expertise
Specialties
- Obstetrics and Gynecology
- Gynecology
Locations
My research
Publications
Showing 1-6 of 21 reviews
- December 4, 20255 out of 5 Stars
She is phenomenal!
- November 6, 20255 out of 5 Stars
Dr. Mindy Goldman is an excellent physician. She listens, cares about your health and is very thorough, she pays attention to details. I am very grateful for her care.
- October 7, 20255 out of 5 Stars
Mindy Goldman is the best physician I've ever seen. She has been my doctor for many years, and even after moving to the East Coast eight years ago I still fly to California to see her.
- September 16, 20255 out of 5 Stars
Dr. Goldman is one of the best providers I've ever had. I will stay with UCSF just to see her.
- September 4, 20255 out of 5 Stars
Outstanding care provider and have had amazing care with her!!!
- August 19, 20255 out of 5 Stars
Dr Goldman is Extremely knowledgeable, professional and compassionate
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.